Negatively controls the transcription of the yiaKLMNOPQRS operon, which may be involved in the utilization of 2,3-diketo-L-gulonate. Expression of yiaJ is autogenously regulated and reduced by the binding of CRP-cAMP to the CRP site 1 of the YiaK-S promoter.